HUS ParisMode de compatibilité]

First Page		Document Content
Date: 2016-05-16 12:27:10 Complement system Blood disorders Eculizumab Immunosuppressants Acquired hemolytic anemia Atypical hemolytic uremic syndrome Thrombotic microangiopathy TMA C5-convertase Nephrology Dialysis Factor H		HUS ParisMode de compatibilité] Add to Reading List Source URL: www.hemapherese.fr Download Document from Source Website File Size: 3,19 MB Share Document on Facebook

	HUS ParisMode de compatibilité] DocID: 1oXIv - View Document
	Carbinoxaminium dipicrate DocID: RAQt - View Document
	© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris DocID: QbAx - View Document
	ALN-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition Anna Borodovsky1; Kristina Yucius1; Andrew Sprague1; Nirmal K. Banda2; V. Michael Holers2; Akshay Vaishnaw1; Martin Maier1; Rajeev Kalla DocID: NNEW - View Document
	ISJ 8: 21-32, 2011 ISSN 1824-307X DocID: 4O1s - View Document